Selin Sen

Selin Sen

Auto-generated profile, based on publicly available information

Selin Sen

Unité des Virus Émergents, UVE: Aix-Marseille Univ, Università di Corsica, IRD 190, INSERM 1207, IRBA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
HBHawa Sophia Bouzidi
Hawa Sophia Bouzidi
SSSelin Sen
Selin Sen
GPGéraldine Piorkowski
Géraldine Piorkowski
LPLaura Pezzi
Laura Pezzi
NANazli Ayhan
Nazli Ayhan
Raphaëlle KlittingRaphaëlle Klitting
Raphaëlle Klitting
Dengue fever is the most important arbovirosis for public health, with more than 5 million cases worldwide in 2023. Mosnodenvir is the first anti-dengue compound with very high preclinical pan-serotype activity, currently undergoing phase 2 clinical evaluation. Here, by analyzing dengue virus (DENV) genomes from the 2023-2024 epidemic in the French Caribbean Islands, we show that they all exhibit mutation NS4B:V91A, previously associated with a marked decrease in sensitivity to mosnodenvir in vitro. Using antiviral activity tests on four clinical and reverse-genetic strains, we confirm a marked decrease in mosnodenvir sensitivity for DENV-2 ( > 1000 fold). Finally, combining phylogenetic analysis and experimental testing for resistance, we find that virus lineages with low sensitivity to mosnodenvir due to the V91A mutation likely emerged multiple times over the last 30 years in DENV-2 and DENV-3. These results call for increased genomic surveillance, in particular to track lineages with resistance mutations. These efforts should allow to better assess the activity profile of DENV treatments in development against circulating strains.

21 May 2025 in medRxiv
Verified
Preprint
Open access
PDF file
PVPaola Mariela Saba Villarroel
Paola Mariela Saba Villarroel
SSSelin Sen
Selin Sen
Raphaëlle KlittingRaphaëlle Klitting
Raphaëlle Klitting
LPLaura Pezzi
Laura Pezzi
GPGeraldine Piorkowski
Geraldine Piorkowski
SWSineewanlaya Wichit
Sineewanlaya Wichit
With Aedes aegypti expanding to higher altitudes, dengue virus (DENV) cases soared to record levels in 2024 in Cochabamba, Bolivia (2,558 meters above sea level). Using genome sequencing, we identified at least two distinct clades of DENV-2 genotype II circulating during the outbreak.